2

Alectinib as first-line therapy for ALK-rearranged NSCLC: A no-brainer?

Year:
2018
Language:
english
File:
PDF, 214 KB
english, 2018
6

Treatment of ALK-positive nonsmall cell lung cancer

Year:
2017
Language:
english
File:
PDF, 304 KB
english, 2017